相关实验视频
Updated: Jun 23, 2025

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.5K
深度图形对比学习模型用于药物相互作用预测
Zhenyu Jiang1, Zhi Gong2,3, Xiaopeng Dai1,2,3
1College of Information and Intelligence, Hunan Agricultural University, Changsha, China.
PloS one
|June 17, 2024
概括
这项研究介绍了DeepGCL,这是一种用于预测药物相互作用 (DDI) 的新型深度图对比学习模型. DeepGCL集成了分子结构和网络拓特征,提高了预测准确性和患者安全.
科学领域:
- 计算化学是一种计算化学.
- 药理学 药理学是指药理学的学科.
- 生物信息学是一种生物信息学.
背景情况:
- 药物相互作用 (DDI) 显著影响治疗疗效和患者安全.
- 目前用于DDI预测的计算方法因分子信息的不完全整合而面临准确性和概括性的挑战.
- 需要先进的计算模型来有效和准确地预测DDI.
研究的目的:
- 开发一种新的深度图对比学习模型 (DeepGCL),用于增强药物相互作用预测.
- 通过整合各种分子数据来提高DDI预测的准确性和概括性.
- 为分析潜在药物相互作用提供强大的计算工具.
主要方法:
- 提出了DeepGCL,一个深度图形对比学习框架.
- 集成的分子结构特征与交互网络拓特征.
- 采用对比学习来增强不同数据视图之间的信息一致性.
主要成果:
- 在所有测试的数据集中,DeepGCL与现有方法相比,表现优越.
- 实验分析证实了每个模型组件的必要性,并突出了其强度.
- 该模型有效地利用结构和网络信息进行准确的DDI预测.
结论:
- DeepGCL在计算药物相互作用预测方面取得了重大进展.
- 该模型能够整合多样化的分子数据,从而提高预测准确性和可靠性.
- 这种方法有望提高药物安全性和优化治疗策略.
相关概念视频
Drug-Receptor Interaction: Antagonist
2.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.9K
Drug-Receptor Interactions
5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K
Combined Effects of Drugs: Antagonism
8.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.4K
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Drug-Receptor Interaction: Agonist
2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K
Drug Concentration Versus Time Correlation
723
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
723

